1. Home
  2. XXII vs CDT Comparison

XXII vs CDT Comparison

Compare XXII & CDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 22nd Century Group Inc.

XXII

22nd Century Group Inc.

HOLD

Current Price

$0.63

Market Cap

949.6K

Sector

Health Care

ML Signal

HOLD

Logo Conduit Pharmaceuticals Inc.

CDT

Conduit Pharmaceuticals Inc.

HOLD

Current Price

$0.21

Market Cap

1.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XXII
CDT
Founded
1998
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
949.6K
1.1M
IPO Year
2011
2022

Fundamental Metrics

Financial Performance
Metric
XXII
CDT
Price
$0.63
$0.21
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
191.3K
★ 1.6M
Earning Date
11-03-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 69.96
N/A
EPS
N/A
★ N/A
Revenue
★ $25,832,530.00
N/A
Revenue This Year
$361.06
N/A
Revenue Next Year
$1,493.14
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.27
$0.07
52 Week High
$11.37
$93,755.00

Technical Indicators

Market Signals
Indicator
XXII
CDT
Relative Strength Index (RSI) 21.78 21.34
Support Level $0.51 $0.07
Resistance Level $2.57 $170.00
Average True Range (ATR) 0.11 0.12
MACD 0.04 4.52
Stochastic Oscillator 7.77 7.25

Price Performance

Historical Comparison
XXII
CDT

About XXII 22nd Century Group Inc.

22nd Century Group Inc is a tobacco products company that enables cigarette smokers to take control of their consumption of nicotine, the addictive drug in cigarettes. The company manufactures and distributes the only combustible tobacco products containing minimally or non-addictive levels of nicotine. The Company has organized its business as a single reportable segment: tobacco, as it operates and derives all revenues from its tobacco operations and products.

About CDT Conduit Pharmaceuticals Inc.

CDT Equity Inc is a data-driven biopharmaceutical development company focused on identifying, enhancing, and advancing high-potential therapeutic assets through scientific innovation and strategic partnerships. It has evolved into a broader, more agile platform that leverages artificial intelligence, solid-form chemistry, and efficient asset repositioning to accelerate the development of novel treatments. The company's pipeline includes candidates that target autoimmune disorders, as well as idiopathic male infertility, oncology, dermatology, rare disease and animal health. It has one operating segment focused on the research and development of clinical assets.

Share on Social Networks: